These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 19121474)

  • 1. Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease.
    Feldt-Rasmussen B; El Nahas M
    Semin Nephrol; 2009 Jan; 29(1):50-8. PubMed ID: 19121474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
    Yuen KC; Dunger DB
    Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
    Yuen KC; Dunger DB
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying the Growth Failure in CKD Consensus Conference: evaluation and treatment algorithm in children with chronic kidney disease.
    Mahan JD
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S68-78. PubMed ID: 16750646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease.
    Kuan Y; Surman J; Frystyk J; El Nahas AM; Flyvbjerg A; Haylor JL
    Growth Horm IGF Res; 2009 Jun; 19(3):219-25. PubMed ID: 19046909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor 1 resistance in chronic renal failure.
    Fouque D
    Miner Electrolyte Metab; 1996; 22(1-3):133-7. PubMed ID: 8676805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease.
    Moinuddin I; Leehey DJ
    Adv Chronic Kidney Dis; 2008 Jan; 15(1):83-96. PubMed ID: 18155113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with growth hormone and insulin-like growth factor-I in critical illness.
    Carroll PV
    Best Pract Res Clin Endocrinol Metab; 2001 Dec; 15(4):435-51. PubMed ID: 11800516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with GH and IGF-1 in critical illness.
    Teng Chung T; Hinds CJ
    Crit Care Clin; 2006 Jan; 22(1):29-40, vi. PubMed ID: 16399018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does growth hormone play a role in chronic heart failure?
    Volterrani M; Giustina A; Lorusso R; Giordano A
    Heart Fail Monit; 2002; 3(2):60-4. PubMed ID: 12634881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of growth hormone and insulin-like growth factor-1 on the aging cardiovascular system and its progenitor cells.
    Devin JK; Young PP
    Curr Opin Investig Drugs; 2008 Sep; 9(9):983-92. PubMed ID: 18729005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malnutrition in hemodialysis patients: what therapy?
    Bossola M; Muscaritoli M; Tazza L; Giungi S; Tortorelli A; Rossi Fanelli F; Luciani G
    Am J Kidney Dis; 2005 Sep; 46(3):371-86. PubMed ID: 16129199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes.
    Flyvbjerg A
    Kidney Int Suppl; 1997 Sep; 60():S12-9. PubMed ID: 9285896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factors in children with end-stage liver disease before and after liver transplantation: a review.
    Maes M; Sokal E; Otte JB
    Pediatr Transplant; 1997 Nov; 1(2):171-5. PubMed ID: 10084777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are the metabolic effects of GH and IGF-I separable?
    Mauras N; Haymond MW
    Growth Horm IGF Res; 2005 Feb; 15(1):19-27. PubMed ID: 15701568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive human growth hormone therapy in nutrition support: potential to limit septic complications in intensive care unit patients.
    Ziegler TR; Leader I
    Semin Respir Infect; 1994 Dec; 9(4):240-7. PubMed ID: 7886321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone in HIV/AIDS: current uses and future prospects.
    Laurence J
    Pediatr AIDS HIV Infect; 1995 Oct; 6(5):281-91. PubMed ID: 11361393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the effects of growth hormone changes on symptoms of frailty in the elderly with chronic kidney disease.
    Abdel-Rahman E; Holley JL
    Semin Dial; 2009; 22(5):532-8. PubMed ID: 19840344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone resistance in chronic heart failure and its therapeutic implications.
    Cicoira M; Kalra PR; Anker SD
    J Card Fail; 2003 Jun; 9(3):219-26. PubMed ID: 12815572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.